Nu Skin Enterprises, Inc.
NUS
$6.55
-$0.08-1.21%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -14.17% | -14.26% | -12.10% | -11.79% | -11.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.17% | -14.26% | -12.10% | -11.79% | -11.85% |
| Cost of Revenue | -12.53% | -11.28% | 4.11% | -7.13% | -5.61% |
| Gross Profit | -14.88% | -15.50% | -17.68% | -13.69% | -14.29% |
| SG&A Expenses | -15.43% | -16.85% | -15.62% | -14.11% | -12.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.50% | -15.11% | -10.11% | -11.97% | -10.71% |
| Operating Income | -8.22% | 1.45% | -33.74% | -8.88% | -28.28% |
| Income Before Tax | 254.50% | 212.08% | 211.38% | 175.49% | -417.40% |
| Income Tax Expenses | 421.80% | 226.48% | 324.78% | 331.43% | -118.32% |
| Earnings from Continuing Operations | 241.45% | 209.28% | 206.20% | 167.92% | -1,063.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 241.45% | 209.28% | 206.20% | 167.92% | -1,063.13% |
| EBIT | -8.22% | 1.45% | -33.74% | -8.88% | -28.28% |
| EBITDA | -14.56% | -10.19% | -30.07% | -11.02% | -21.32% |
| EPS Basic | 242.44% | 209.55% | 206.29% | 167.96% | -1,080.00% |
| Normalized Basic EPS | 36.09% | 53.65% | 11.06% | 39.40% | -27.91% |
| EPS Diluted | 235.83% | 208.05% | 204.71% | 167.13% | -1,004.01% |
| Normalized Diluted EPS | 35.35% | 52.56% | 10.37% | 39.35% | -27.84% |
| Average Basic Shares Outstanding | -1.63% | -0.74% | -0.01% | 0.06% | 0.07% |
| Average Diluted Shares Outstanding | -0.16% | 0.69% | 0.71% | 0.36% | 0.21% |
| Dividend Per Share | 0.00% | 0.00% | -57.89% | -73.33% | -80.49% |
| Payout Ratio | 1.69% | 1.91% | 1.40% | 1.39% | 0.98% |